2m 2m 2m 2m 2m 2m 2m
AMNEAL PHRMCTL-A (AMRX)
NASDAQ
$21.36-$0.35 (-1.61%)
Price as of Nov 12, 2026 8:25 AM EST- $7.6BMarket Cap
- 82.44%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
AMNEAL PHRMCTL-A (AMRX)
$21.36-$0.35 (-1.61%)
AMRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.71 | ||
Change | +$0.33 (+1.54%) | ||
Open | $21.47 | ||
High | $22.00 | ||
Low | $21.44 | ||
Previous Close | $21.38 | ||
Volume | 2,470,526 | ||
30-Day Average Volume | 4,442,202 | ||
1-Week Change | 8.82% | ||
1-Month Change | 9.04% | ||
1-Year Change | 82.44% | ||
3-Year Change | 414.45% | ||
5-Year Change | 312.74% | ||
Fundamentals | |||
Shares Outstanding | 348.3M | ||
Total Assets | $5.3B | ||
Market Cap | $7.6B | ||
Enterprise Value | $10.5B | ||
Period: QTR TTM FY | |||
Revenue | $862.7M | ||
Net Income | -$21.7M | ||
Free Cash Flow | $66.5M | ||
EBIT | $40.0M | ||
EBITDA | $78.6M | ||
Net Working Capital | $975.2M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | 134 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 14 | ||
P/E | -362 | ||
PEG | 3 | ||
Price/Free Cash Flow | 114 | ||
Price/Operating Cash Flow | 77 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 08/26/2013 | ||
Earnings & Revenue